A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity
Top Cited Papers
- 29 April 2008
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (17) , 6439-6444
- https://doi.org/10.1073/pnas.0802082105
Abstract
Protein misfolding is intimately associated with devastating human neurodegenerative diseases, including Alzheimer's, Huntington's, and Parkinson's. Although disparate in their pathophysiology, many of these disorders share a common theme, manifested in the accumulation of insoluble protein aggregates in the brain. Recently, the major disease protein found in the pathological inclusions of two of these diseases, amyotrophic lateral sclerosis (ALS) and frontal temporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U), was identified as the 43-kDa TAR-DNA-binding protein (TDP-43), providing a molecular link between them. TDP-43 is a ubiquitously expressed nuclear protein that undergoes a pathological conversion to an aggregated cytoplasmic localization in affected regions of the nervous system. Whether TDP-43 itself can convey toxicity and whether its abnormal aggregation is a cause or consequence of pathogenesis remain unknown. We report a yeast model to define mechanisms governing TDP-43 subcellular localization and aggregation. Remarkably, this simple model recapitulates several salient features of human TDP-43 proteinopathies, including conversion from nuclear localization to cytoplasmic aggregation. We establish a connection between this aggregation and toxicity. The pathological features of TDP-43 are distinct from those of yeast models of other protein-misfolding diseases, such as polyglutamine. This suggests that the yeast model reveals specific aspects of the underlying biology of the disease protein rather than general cellular stresses associated with accumulating misfolded proteins. This work provides a mechanistic framework for investigating the toxicity of TDP-43 aggregation relevant to human disease and establishes a manipulable, high-throughput model for discovering potential therapeutic strategies.Keywords
This publication has 69 references indexed in Scilit:
- Evidence against Involvement of Aquaporin-4 in Cell–Cell AdhesionJournal of Molecular Biology, 2008
- TDP‐43 A315T mutation in familial motor neuron diseaseAnnals of Neurology, 2008
- The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasisProceedings of the National Academy of Sciences, 2008
- TDP-43: a novel neurodegenerative proteinopathyCurrent Opinion in Neurobiology, 2007
- A network of protein interactions determines polyglutamine toxicityProceedings of the National Academy of Sciences, 2006
- Flanking sequences profoundly alter polyglutamine toxicity in yeastProceedings of the National Academy of Sciences, 2006
- Frontotemporal dementia: Clinicopathological correlationsAnnals of Neurology, 2006
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- Protein folding and misfoldingNature, 2003
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997